馃嚫馃嚜 Apotea

APOTEA.ST
Healthcare Sweden SEK Ex-Div 2026-05-27 apotea.se
Fundamentals
Gross Margin
26.9%
Op. Margin
4.2%
Net Margin
3.2%
ROIC
28.2%
Rev Growth
10.1%
Valuation
Price
77.00 SEK
Day
-0.39%
52-Week Range
54.42 - 98.49
Market Cap
8.0B SEK
Fwd P/E
21.6x
EV/EBITDA
18.2x
Div Yield
0.78%
Annual income statement #

Apotea annual revenue, operating income and net income in SEK, 2021 to 2025. Revenue was 7.20bn in 2025.

Year Revenue (SEK) Operating income Net income Net margin
2025 7.20bn 303.7m 228.7m 3.2%
2024 6.54bn 262.8m 214.9m 3.3%
2023 5.45bn 112.7m 87.0m 1.6%
2022 4.88bn 49.0m 19.9m 0.4%
2021 4.56bn 133.6m 104.5m 2.3%
Financial Data #
Segment Breakdown #
Price & Multiples #
Peers #
Short Interest #
Current: 1.28% 30d ago: 2.05% All-time high: 4.53% (2026-03-13)
Events #
Date Type Details Price Amount